Unigestion Holding Sa Abb Vie Inc. Transaction History

Unigestion Holding Sa

$1.87 Billion
Q2 2024

A detailed history of Unigestion Holding Sa transactions in Abb Vie Inc. stock. As of the latest transaction made, Unigestion Holding Sa holds 104,677 shares of ABBV stock, worth $21.3 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

104,677

Previous 113,578 7.84%

Holding current value

$21.3 Million

Previous $20.7 Million 13.19%

% of portfolio

0.96%

Previous 1.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $1.38 Million - $1.61 Million	-8,901 Reduced 7.84%	104,677 $18 Million
Q1 2024 May 08, 2024	BUY	$159.82 - $182.1 $1.42 Million - $1.62 Million	8,901 Added 8.5%	113,578 $20.7 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $9.64 Million - $10.9 Million	-70,023 Reduced 40.08%	104,677 $16.2 Million
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $1.4 Million - $1.62 Million	-10,499 Reduced 5.67%	174,700 $26 Million
Q2 2023 Jul 27, 2023	SELL	$132.51 - $164.9 $10.6 Million - $13.2 Million	-79,796 Reduced 30.11%	185,199 $25 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $2.26 Million - $2.6 Million	-15,599 Reduced 5.56%	264,995 $42.2 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $3.06 Million - $3.67 Million	22,101 Added 8.55%	280,594 $45.4 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $6.86 Million - $7.86 Million	51,085 Added 24.63%	258,493 $36.9 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $1.9 Million - $2.41 Million	13,790 Added 7.12%	207,408 $31.8 Million
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $4.61 Million - $5.71 Million	34,895 Added 21.98%	193,618 $31.4 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $7.93 Million - $10 Million	73,850 Added 87.01%	158,723 $21.5 Million
Q3 2021 Oct 14, 2021	SELL	$106.4 - $120.78 $875,246 - $993,536	-8,226 Reduced 8.84%	84,873 $9.16 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $4.01 Million - $4.47 Million	38,135 Added 69.38%	93,099 $10.5 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $4.35 Million - $4.79 Million	42,527 Added 341.94%	54,964 $5.95 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $1.99 Million - $2.69 Million	-24,775 Reduced 66.58%	12,437 $1.33 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $3.2 Million - $3.75 Million	37,212 New	37,212 $3.26 Million
Q3 2019 Nov 04, 2019	SELL	$62.98 - $75.72 $1.59 Million - $1.91 Million	-25,187 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $2.74 Million - $3.23 Million	-35,571 Reduced 58.55%	25,187 $2.03 Million
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $2.39 Million - $2.66 Million	-26,902 Reduced 30.69%	60,758 $5.75 Million
Q2 2018 Jul 24, 2018	BUY	$89.78 - $106.23 $7.87 Million - $9.31 Million	87,660 New	87,660 $8.12 Million

Others Institutions Holding ABBV

# of Institutions

3,767

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $360B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Unigestion Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Unigestion Holding Sa with notifications on news.

Account

Unigestion Holding Sa Abb Vie Inc. Transaction History